Mucommune
Keiichiro Kushiro is currently the Director of Research at Mucommune, LLC. Keiichiro previously worked as a Project Lecturer/Associate Professor at The University of Tokyo and as a Postdoctoral Scholar in Chemical Engineering at Northeastern University and California Institute of Technology. Keiichiro's research primarily focuses on the investigation of cell-polymer bio-interface. Keiichiro holds a Ph.D. in Biochemistry/Cell Engineering from Caltech and a B.S. in Chemical and Biomolecular Engineering from Cornell University.
Mucommune
Mucommune is a privately-held preclinical stage company launched based on the “muco-trapping” monoclonal antibodies (mAb) platform developed at Johns Hopkins University and University of North Carolina at Chapel Hill.